サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1654297

敗血症治療薬の世界市場：市場規模・シェア・動向分析 (薬剤クラス別・投与経路別・流通チャネル別・地域別)、セグメント別予測 (2025年～2030年)

Sepsis Therapeutics Market Size, Share & Trends Analysis Report By Drug Class (Cephalosporin, Glycopeptide, Aminoglycosides), By Route Of Administration (Parenteral, Oral), By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2030

出版日
ページ情報
英文 153 Pages
納期
2～10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
敗血症治療薬の世界市場：市場規模・シェア・動向分析 (薬剤クラス別・投与経路別・流通チャネル別・地域別)、セグメント別予測 (2025年～2030年)
出版日: 2025年01月22日
発行: Grand View Research
ページ情報: 英文 153 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

敗血症治療薬市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、世界の敗血症治療薬の市場規模は2030年までに56億4,000万米ドルに達し、2025年から2030年までのCAGRは6.18%で成長すると予測されています。

敗血症治療薬業界は、敗血症の有病率の増加と効果的な治療オプションに対する需要の高まりにより、大きな成長を遂げています。敗血症は、感染症によって引き起こされる生命を脅かす病態であり、特に高齢者や免疫力が低下した人などの脆弱な集団の間で、世界の死亡率の主要原因となっています。敗血症に対する意識の高まりは、医療インフラの進歩とともに、新規かつ効果的な治療法に対する需要を促進し、市場の成長を後押ししています。

市場の拡大に寄与している主な要因は、治療に使用される抗生物質の種類が豊富なことです。ゲンタマイシンなどのアミノグリコシド系抗生物質は、グラム陰性菌に対する広域スペクトル活性により、敗血症管理の主力薬であり続けています。さらに、セファロスポリン系抗菌薬は、様々な感染症、特にグラム陽性菌による感染症の治療に有効であるため、広く処方されています。バンコマイシンのような糖ペプチドも敗血症の治療、特に耐性感染症に重要です。カルバペネム系抗菌薬やβラクタム系抗菌薬のような他の薬剤クラスの存在は、治療の展望をさらに広げています。

敗血症治療薬は、経口剤、非経口剤 (注射剤)、その他の製剤など、さまざまな形態で入手可能であるため、さまざまな医療環境において患者にとって利用しやすく、汎用性が高いです。経口薬は外来治療に便利である一方、非経口製剤は即時の介入が必要な重症例に不可欠です。また、他の剤形が利用可能になりつつあることも、個別化医療を支えています。

流通経路の面では、病院薬局が引き続き敗血症治療薬の一次情報源であり、重症治療室に必要な治療薬がストックされていることを保証しています。小売薬局は利用しやすい医薬品を提供することでその役割を拡大しており、一方、オンライン薬局は敗血症治療薬への容易なアクセスを提供することで支持を集め、市場の成長をさらに後押ししています。医療へのアクセスや治療に対する認識が世界的に高まるにつれ、敗血症治療薬業界は今後数年間で継続的な拡大を遂げる構えです。

敗血症治療薬市場のレポートハイライト

  • 薬剤クラス別では、セファロスポリンが2024年に最大の市場シェアを占めました。この優位性は、グラム陽性およびグラム陰性病原体の両方を含む広範囲の細菌感染に対するセファロスポリンの広域効能に起因します。
  • 投与経路別では、非経口製剤が2024年の市場を独占しました。静脈注射や筋肉注射を含む非経口製剤は、迅速なデリバリーと高い生物学的利用能を提供するため、特に重症患者を対象とした敗血症の即時治療に不可欠です。
  • 流通チャネル別では、病院薬局が2024年も支配的なセグメントです。病院薬局は、特に集中治療室 (ICU) や救命治療への迅速なアクセスが不可欠な救急部において、敗血症治療薬をタイムリーかつ適切に提供するために重要です。
  • 2024年の敗血症治療薬市場は北米が支配的でしたが、これは高度な医療インフラ、疾患有病率の上昇、良好な規制環境などの要因によるものでした。

目次

第1章 分析方法・範囲

第2章 エグゼクティブサマリー

第3章 敗血症治療薬市場：変動要因・傾向・範囲

  • 親市場の見通し
  • 関連/付随市場の見通し
  • 市場力学
    • 市場促進要因の分析
    • 市場抑制要因の分析
  • 敗血症治療薬市場：分析ツール
    • ポーターのファイブフォース分析
    • PESTEL分析

第4章 敗血症治療薬市場：種類別の展望・推定・予測

  • 敗血症治療薬市場：種類別ダッシュボード
  • 敗血症治療薬市場：変動分析、種類別 (2024年・2030年)
  • セファロスポリン
  • アミノグリコシド
  • 糖ペプチド
  • その他の薬剤クラス

第5章 敗血症治療薬市場：投与経路別の展望・推定・予測

  • 敗血症治療薬市場：投与経路別のダッシュボード
  • 敗血症治療薬市場：変動分析、投与経路別 (2024年・2030年)
  • 非経口
  • 経口
  • その他

第6章 敗血症治療薬市場：流通チャネル別の展望・推定・予測

  • 敗血症治療薬市場：流通チャネル別のダッシュボード
  • 敗血症治療薬市場：変動分析、流通チャネル別 (2024年・2030年)
  • 病院薬局
  • 小売薬局
  • オンライン薬局

第7章 敗血症治療薬市場：地域別の展望・推定・予測

  • 敗血症治療薬の市場シェア：地域別 (2024年・2030年)
  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • デンマーク
    • ノルウェー
    • スウェーデン
  • アジア太平洋
    • 中国
    • 日本
    • インド
    • 韓国
    • オーストラリア
    • タイ
  • ラテンアメリカ
    • ブラジル
    • アルゼンチン
  • 中東・アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • クウェート
    • 南アフリカ

第8章 競合情勢

  • 最近の動向と影響分析：主要な市場参入企業別
  • 企業分類
  • 企業ヒートマップ分析
  • 企業プロファイル
    • Pfizer, Inc.
    • GSK plc.
    • AstraZeneca
    • Eli Lilly and Company
    • Astellas Pharma Inc.
    • Asahi Kasei Corporation
    • InflaRx GmbH
    • La Jolla Pharmaceutical Co.
    • T2 Biosystems Inc.
    • Aridis Pharmaceuticals Inc.
図表

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Global Sepsis Therapeutics Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 4 Global Sepsis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 5 Global Sepsis Therapeutics Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 6 North America Sepsis Therapeutics Market, by Country, 2018 - 2030 (USD Million)
  • Table 7 North America Sepsis Therapeutics Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 8 North America Sepsis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 9 North America Sepsis Therapeutics Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 10 U.S. Sepsis Therapeutics Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 11 U.S. Sepsis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 12 U.S. Sepsis Therapeutics Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 13 Canada Sepsis Therapeutics Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 14 Canada Sepsis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 15 Canada Sepsis Therapeutics Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 16 Mexico Sepsis Therapeutics Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 17 Mexico Sepsis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 18 Mexico Sepsis Therapeutics Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 19 Europe Sepsis Therapeutics Market, by Country, 2018 - 2030 (USD Million)
  • Table 20 Europe Sepsis Therapeutics Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 21 Europe Sepsis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 22 Europe Sepsis Therapeutics Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 23 Germany Sepsis Therapeutics Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 24 Germany Sepsis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 25 Germany Sepsis Therapeutics Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 26 UK Sepsis Therapeutics Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 27 UK Sepsis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 28 UK Sepsis Therapeutics Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 29 France Sepsis Therapeutics Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 30 France Sepsis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 31 France Sepsis Therapeutics Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 32 Italy Sepsis Therapeutics Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 33 Italy Sepsis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 34 Italy Sepsis Therapeutics Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 35 Spain Sepsis Therapeutics Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 36 Spain Sepsis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 37 Spain Sepsis Therapeutics Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 38 Denmark Sepsis Therapeutics Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 39 Denmark Sepsis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 40 Denmark Sepsis Therapeutics Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 41 Sweden Sepsis Therapeutics Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 42 Sweden Sepsis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 43 Sweden Sepsis Therapeutics Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 44 Norway Sepsis Therapeutics Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 45 Norway Sepsis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 46 Norway Sepsis Therapeutics Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 47 Asia Pacific Sepsis Therapeutics Market, by Country, 2018 - 2030 (USD Million)
  • Table 48 Asia Pacific Sepsis Therapeutics Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 49 Asia Pacific Sepsis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 50 Asia Pacific Sepsis Therapeutics Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 51 China Sepsis Therapeutics Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 52 China Sepsis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 53 China Sepsis Therapeutics Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 54 Japan Sepsis Therapeutics Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 55 Japan Sepsis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 56 Japan Sepsis Therapeutics Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 57 India Sepsis Therapeutics Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 58 India Sepsis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 59 India Sepsis Therapeutics Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 60 South Korea Sepsis Therapeutics Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 61 South Korea Sepsis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 62 South Korea Sepsis Therapeutics Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 63 Australia Sepsis Therapeutics Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 64 Australia Sepsis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 65 Australia Sepsis Therapeutics Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 66 Thailand Sepsis Therapeutics Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 67 Thailand Sepsis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 68 Thailand Sepsis Therapeutics Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 69 Latin America Sepsis Therapeutics Market, by Country, 2018 - 2030 (USD Million)
  • Table 70 Latin America Sepsis Therapeutics Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 71 Latin America Sepsis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 72 Latin America Sepsis Therapeutics Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 73 Brazil Sepsis Therapeutics Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 74 Brazil Sepsis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 75 Brazil Sepsis Therapeutics Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 76 Argentina Sepsis Therapeutics Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 77 Argentina Sepsis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 78 Argentina Sepsis Therapeutics Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 79 Middle East & Africa Sepsis Therapeutics Market, by Country, 2018 - 2030 (USD Million)
  • Table 80 Middle East & Africa Sepsis Therapeutics Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 81 Middle East & Africa Sepsis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 82 Middle East & Africa Sepsis Therapeutics Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 83 South Africa Sepsis Therapeutics Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 84 South Africa Sepsis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 85 South Africa Sepsis Therapeutics Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 86 Saudi Arabia Sepsis Therapeutics Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 87 Saudi Arabia Sepsis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 88 Saudi Arabia Sepsis Therapeutics Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 89 UAE Sepsis Therapeutics Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 90 UAE Sepsis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 91 UAE Sepsis Therapeutics Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 92 Kuwait Sepsis Therapeutics Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 93 Kuwait Sepsis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 94 Kuwait Sepsis Therapeutics Market, by Distribution Channel, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information Procurement
  • Fig. 3 Primary Research Pattern
  • Fig. 4 Market Research Approaches
  • Fig. 5 Value Chain-Based Sizing & Forecasting
  • Fig. 6 Market Formulation & Validation
  • Fig. 7 Sepsis therapeutics market Segmentation
  • Fig. 8 Market Snapshot, 2024
  • Fig. 9 Market Trends & Outlook
  • Fig. 10 Market driver relevance analysis (current & future impact)
  • Fig. 11 Market restraint relevance analysis (current & future impact)
  • Fig. 12 Market challenge relevance analysis (current & future impact)
  • Fig. 13 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • Fig. 14 Porter's Five Forces Analysis
  • Fig. 15 Sepsis therapeutics market: Drug class movement analysis
  • Fig. 16 Sepsis therapeutics market: Drug class Outlook and key takeaways
  • Fig. 17 Cephalosporin sepsis therapeutics market estimates and forecasts, 2018 - 2030
  • Fig. 18 Aminoglycosides sepsis therapeutics market estimates and forecasts, 2018 - 2030
  • Fig. 19 Glycopeptide sepsis therapeutics market estimates and forecasts, 2018 - 2030
  • Fig. 20 Glycopeptide sepsis therapeutics market estimates and forecasts, 2018 - 2030
  • Fig. 21 Sepsis therapeutics market: Treatment movement analysis
  • Fig. 22 Sepsis therapeutics market: Treatment outlook and key takeaways
  • Fig. 23 Parenteral market estimates and forecasts, 2018 - 2030
  • Fig. 24 Oral market estimates and forecasts, 2018 - 2030
  • Fig. 25 Others market estimates and forecasts, 2018 - 2030
  • Fig. 26 Sepsis therapeutics market: Distribution channel movement analysis
  • Fig. 27 Sepsis therapeutics market: Distribution channel outlook and key takeaways
  • Fig. 28 Hospital pharmacies market estimates and forecasts, 2018 - 2030
  • Fig. 29 Retail pharmacies market estimates and forecasts, 2018 - 2030
  • Fig. 30 Online pharmacies market estimates and forecasts, 2018 - 2030
  • Fig. 31 Regional Marketplace: Key Takeaways
  • Fig. 32 Regional Outlook, 2024 & 2030
  • Fig. 33 Global sepsis therapeutics market, Region Movement Analysis
  • Fig. 34 North America sepsis therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 35 U.S. sepsis therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 36 Canada sepsis therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 37 Mexico sepsis therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 38 Europe sepsis therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 39 Germany sepsis therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 40 UK sepsis therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 41 France sepsis therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 42 Italy sepsis therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 43 Spain sepsis therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 44 Denmark sepsis therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 45 Sweden sepsis therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 46 Norway sepsis therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 47 Asia Pacific sepsis therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 48 Japan sepsis therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 49 China sepsis therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 50 India sepsis therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 51 Australia sepsis therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 52 South Korea sepsis therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 53 Thailand sepsis therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 54 Latin America sepsis therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 55 Brazil sepsis therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 56 Argentina sepsis therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 57 Middle East and Africa sepsis therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 58 South Africa sepsis therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 59 Saudi Arabia sepsis therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 60 UAE sepsis therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 61 Kuwait sepsis therapeutics market, 2018 - 2030 (USD Million)
目次
Product Code: GVR-4-68040-506-0

Sepsis Therapeutics Market Growth & Trends:

The global sepsis therapeutics market size is anticipated to reach USD 5.64 billion by 2030, growing at a CAGR of 6.18% from 2025 to 2030, according to a new report by Grand View Research, Inc. The sepsis therapeutics industry is experiencing significant growth due to the increasing prevalence of sepsis and the rising demand for effective treatment options. Sepsis, a life-threatening condition triggered by an infection, is a leading cause of mortality globally, particularly among vulnerable populations such as the elderly and those with compromised immune systems. The growing awareness about sepsis, alongside advancements in healthcare infrastructure, is driving the demand for novel and effective therapies, propelling market growth.

A key factor contributing to the expansion of the market is the wide range of antibiotics used in the treatment. Aminoglycosides, such as gentamicin, continue to be a mainstay in sepsis management due to their broad-spectrum activity against Gram-negative bacteria. Additionally, cephalosporins are widely prescribed because of their effectiveness in treating various infections, especially those caused by Gram-positive bacteria. Glycopeptides, such as vancomycin, are also critical in sepsis therapy, particularly for resistant infections. The presence of other drug classes like carbapenems and beta-lactams further enhances the treatment landscape.

The availability of sepsis therapeutics in various forms, including oral, parenteral (injectable), and other formulations, ensures better accessibility and versatility for patients across different healthcare settings. Oral medications are convenient for outpatient treatment, while parenteral formulations are vital for severe cases requiring immediate intervention. The growing availability of other drug forms also supports personalized care.

In terms of distribution channels, hospital pharmacies continue to be the primary source of sepsis therapeutics, ensuring that critical care units are stocked with necessary treatments. Retail pharmacies are expanding their role in providing accessible medications, while online pharmacies are gaining traction by offering easy access to sepsis drugs, further boosting market growth. As healthcare access and treatment awareness increase globally, the sepsis therapeutics industry is poised for continued expansion in the coming years.

Sepsis Therapeutics Market Report Highlights:

  • The drug class segment of cephalosporins held the largest market share in 2024. This dominance can be attributed to the broad-spectrum efficacy of cephalosporins against a wide range of bacterial infections, including both Gram-positive and Gram-negative pathogens.
  • In the route of administration segment, parenteral formulations dominated the market in 2024. Parenteral drugs, including intravenous and intramuscular injections, offer rapid delivery and higher bioavailability, making them essential for the immediate treatment of sepsis, especially in critical care settings.
  • Based on distribution channel, hospital pharmacies remained the dominant segment in 2024. Hospital pharmacies are critical in ensuring timely and adequate provision of sepsis therapeutics, particularly in intensive care units (ICUs) and emergency departments where quick access to lifesaving treatments is essential.
  • North America dominated the market for sepsis therapeutics in 2024, owing to factors such as advanced healthcare infrastructure, rising disease prevalence, and favorable regulatory environment.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
    • 1.3.1. Information Procurement
    • 1.3.2. Information or Data Analysis
    • 1.3.3. Market Formulation & Data Visualization
    • 1.3.4. Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Sepsis Therapeutics Market Variables, Trends, & Scope

  • 3.1. Parent Market Outlook
  • 3.2. Ancillary Market Outlook
  • 3.3. Market Dynamics
    • 3.3.1. Market Drivers Analysis
      • 3.3.1.1. Increasing prevalence of sepsis cases
      • 3.3.1.2. Advancements in modern therapeutics
      • 3.3.1.3. Rising investment in sepsis research and drug development
    • 3.3.2. Market Restraints Analysis
      • 3.3.2.1. High cost of advanced therapies
      • 3.3.2.2. Lack of awareness and early diagnosis in some regions
  • 3.4. Sepsis Therapeutics Analysis Tools
    • 3.4.1. Porter's Analysis
      • 3.4.1.1. Bargaining power of the suppliers
      • 3.4.1.2. Bargaining power of the buyers
      • 3.4.1.3. Threats of substitution
      • 3.4.1.4. Threats from new entrants
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Economic and Social landscape
      • 3.4.2.3. Technological landscape
      • 3.4.2.4. Environmental landscape
      • 3.4.2.5. Legal landscape

Chapter 4. Sepsis Therapeutics Market: Type Estimates & Trend Analysis

  • 4.1. Sepsis Therapeutics Market: Type Segment Dashboard
  • 4.2. Sepsis Therapeutics Market: By Type Movement Analysis, 2024 & 2030 (USD Million)
  • 4.3. Cephalosporin
    • 4.3.1. Cephalosporin Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4. Aminoglycosides
    • 4.4.1. Aminoglycosides Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5. Glycopeptide
    • 4.5.1. Glycopeptide Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.6. Other Drug Class
    • 4.6.1. Other Drug Class Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Sepsis Therapeutics Market: Route of Administration Estimates & Trend Analysis

  • 5.1. Sepsis Therapeutics Market: Route of Administration Segment Dashboard
  • 5.2. Sepsis Therapeutics Market: By Route of Administration Movement Analysis, 2024 & 2030 (USD Million)
  • 5.3. Parenteral
    • 5.3.1. Parenteral Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.4. Oral
    • 5.4.1. Oral Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5. Others
    • 5.5.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Sepsis Therapeutics Market: Distribution Channel Estimates & Trend Analysis

  • 6.1. Sepsis Therapeutics Market: Distribution Channel Segment Dashboard
  • 6.2. Sepsis Therapeutics Market: Distribution Channel Movement Analysis, 2024 & 2030 (USD Million)
  • 6.3. Hospital Pharmacies
    • 6.3.1. Hospital Pharmacies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4. Retail Pharmacies
    • 6.4.1. Retail Pharmacies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Online Pharmacies
    • 6.5.1. Online Pharmacies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Sepsis Therapeutics Market: Regional Estimates & Trend Analysis

  • 7.1. Sepsis Therapeutics Market Share, By Region, 2024 & 2030 (USD Million)
  • 7.2. North America
    • 7.2.1. North America Sepsis Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.2.2. U.S.
      • 7.2.2.1. U.S. Sepsis Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.2.3. Canada
      • 7.2.3.1. Canada Sepsis Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.2.4. Mexico
      • 7.2.4.1. Mexico Sepsis Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.3. Europe
    • 7.3.1. Europe Sepsis Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.2. UK
      • 7.3.2.1. UK Sepsis Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.3. Germany
      • 7.3.3.1. Germany Sepsis Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.4. France
      • 7.3.4.1. France Sepsis Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.5. Italy
      • 7.3.5.1. Italy Sepsis Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.6. Spain
      • 7.3.6.1. Spain Sepsis Therapeutics Market Estimates and Forecasts, 2018- 2030 (USD Million)
    • 7.3.7. Denmark
      • 7.3.7.1. Denmark Sepsis Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.8. Norway
      • 7.3.8.1. Norway Sepsis Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.9. Sweden
      • 7.3.9.1. Sweden Sepsis Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.4. Asia Pacific
    • 7.4.1. Asia Pacific Sepsis Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.2. China
      • 7.4.2.1. China Sepsis Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.3. Japan
      • 7.4.3.1. Japan Sepsis Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.4. India
      • 7.4.4.1. India Sepsis Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.5. South Korea
      • 7.4.5.1. South Korea Sepsis Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.6. Australia
      • 7.4.6.1. Australia Sepsis Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.7. Thailand
      • 7.4.7.1. Thailand Sepsis Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5. Latin America
    • 7.5.1. Latin America Sepsis Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.2. Brazil
      • 7.5.2.1. Brazil Sepsis Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.3. Argentina
      • 7.5.3.1. Argentina Sepsis Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6. Middle East and Africa
    • 7.6.1. Middle East and Africa Sepsis Therapeutics Market Estimates and Forecasts, 2017 - 2030 (USD Million)
    • 7.6.2. Saudi Arabia
      • 7.6.2.1. Saudi Arabia Sepsis Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.3. UAE
      • 7.6.3.1. UAE Sepsis Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.4. Kuwait
      • 7.6.4.1. Kuwait Sepsis Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.5. South Africa
      • 7.6.5.1. South Africa Sepsis Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis by Key Market Participants
  • 8.2. Company Categorization
  • 8.3. Company Heat Map Analysis
  • 8.4. Company Profiles
    • 8.4.1. Pfizer, Inc.
      • 8.4.1.1. Participant's Overview
      • 8.4.1.2. Financial Performance
      • 8.4.1.3. Product Benchmarking
      • 8.4.1.4. Recent Developments/ Strategic Initiatives
    • 8.4.2. GSK plc.
      • 8.4.2.1. Participant's Overview
      • 8.4.2.2. Financial Performance
      • 8.4.2.3. Product Benchmarking
      • 8.4.2.4. Recent Developments/ Strategic Initiatives
    • 8.4.3. AstraZeneca
      • 8.4.3.1. Participant's Overview
      • 8.4.3.2. Financial Performance
      • 8.4.3.3. Product Benchmarking
      • 8.4.3.4. Recent Developments/ Strategic Initiatives
    • 8.4.4. Eli Lilly and Company
      • 8.4.4.1. Participant's Overview
      • 8.4.4.2. Financial Performance
      • 8.4.4.3. Product Benchmarking
      • 8.4.4.4. Recent Developments/ Strategic Initiatives
    • 8.4.5. Astellas Pharma Inc.
      • 8.4.5.1. Participant's Overview
      • 8.4.5.2. Financial Performance
      • 8.4.5.3. Product Benchmarking
      • 8.4.5.4. Recent Developments/ Strategic Initiatives
    • 8.4.6. Asahi Kasei Corporation
      • 8.4.6.1. Participant's Overview
      • 8.4.6.2. Financial Performance
      • 8.4.6.3. Product Benchmarking
      • 8.4.6.4. Recent Developments/ Strategic Initiatives
    • 8.4.7. InflaRx GmbH
      • 8.4.7.1. Participant's Overview
      • 8.4.7.2. Financial Performance
      • 8.4.7.3. Product Benchmarking
      • 8.4.7.4. Recent Developments/ Strategic Initiatives
    • 8.4.8. La Jolla Pharmaceutical Co.
      • 8.4.8.1. Participant's Overview
      • 8.4.8.2. Financial Performance
      • 8.4.8.3. Product Benchmarking
      • 8.4.8.4. Recent Developments/ Strategic Initiatives
    • 8.4.9. T2 Biosystems Inc.
      • 8.4.9.1. Participant's Overview
      • 8.4.9.2. Financial Performance
      • 8.4.9.3. Product Benchmarking
      • 8.4.9.4. Recent Developments/ Strategic Initiatives
    • 8.4.10. Aridis Pharmaceuticals Inc.
      • 8.4.10.1. Participant's Overview
      • 8.4.10.2. Financial Performance
      • 8.4.10.3. Product Benchmarking
      • 8.4.10.4. Recent Developments/ Strategic Initiatives